Open-Label Placebo Trial among Japanese Patients with Chronic Low Back Pain

Table 2

Changes in outcomes at week 3 and week 12

		Changes from baseline (n = 26)	Changes from baseline (n = 24)
		Week 3	Week 12
RMDQ (range: 0–24)	TAU	−1.4 (3.6), 1.0 [−3.0, 0.0]	−2.3 (3.2), −2.0 [−2.3, −0.8]
	TAU + OLP	−2.2 (2.9), −1.0 [−4.0, 0.0]	−3.3 (3.2), −3.0 [−5.0, −0.8]
NRS (range: 0–10)	TAU	−0.2 (1.8), 0 [−1.8, 1.0]	−0.8 (1.9), −1 [−2.0, 1.0]
	TAU + OLP	−0.9 (1.8), −1.0 [−1.0, 0.0]	−1.1 (1.9), −1.0 [−2.0, 0.0]
TUG (sec)	TAU	−0.7 (1.5), −0.5 [−1.4, −0.1]	−1.1 (1.1), −1.0 [−1.7, −0.3]
	TAU + OLP	−0.7 (1.0), −0.4 [−1.0, −0.2]	−0.6 (1.5), −0.4 [−1.0, 0.0]

Data are present as mean (standard deviation) and median (interquartile range).